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Abstract 
Background: Impairments in the attribution of salience are thought to be fundamental to the 
development of psychotic symptoms and the onset of psychotic disorders. The aim of the present 
study was to explore longitudinal alterations in salience processing in ultra high-risk subjects for 
psychosis.  
Methods: 23 ultra high-risk subjects and 13 healthy controls underwent functional magnetic 
resonance imaging at two time points (mean interval of 17 months) while performing the Salience 
Attribution Test to assess neural responses to task-relevant (adaptive salience) and task-irrelevant 
(aberrant salience) stimulus features. 
Results: At presentation, high-risk subjects were less likely than controls to attribute salience to 
relevant features, and more likely to attribute salience to irrelevant stimulus features. These 
behavioural differences were no longer evident at follow-up. When attributing salience to relevant cue 
features, ultra high-risk subjects showed less activation than controls in the ventral striatum at both 
baseline and follow-up. Within the high-risk sample, amelioration of abnormal beliefs over the follow-
up period was correlated with an increase in right ventral striatum activation during the attribution of 
salience to relevant cue features.  
Conclusions: These findings confirm that salience processing is perturbed in ultra high-risk subjects 
for psychosis, that this is linked to alterations in ventral striatum function, and that clinical outcomes 
are related to longitudinal changes in ventral striatum function during salience processing.  
 
Declaration of interest 
None. 
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Introduction 
According to the aberrant salience model of psychosis (Heinz, 2002, Howes & Murray, 2014, Kapur, 
2003), psychotic symptoms develop as a result of the inappropriate assignment of salience to 
contextually irrelevant internal and external experiences. This model is supported by evidence that 
patients with schizophrenia respond faster to task-irrelevant stimulus features than healthy controls 
(Pankow et al., 2016), and that patients with prominent delusions rate irrelevant stimuli as more 
potentially rewarding than patients without delusions (Roiser et al., 2009). This ‘aberrant’ attribution 
of salience is also evident in people at ultra high-risk (UHR) for psychosis, who are more likely to 
attribute salience to irrelevant stimulus features than healthy controls, with this tendency again related 
to the severity of abnormal beliefs (Roiser et al., 2013).   
 
Experiments in animals suggest that stimuli become motivationally salient when the release of 
dopamine in the striatum coincides with their perception (Kapur, 2003, Schultz et al., 1997). In healthy 
individuals, aberrant salience measures are positively associated with ventral striatal (VS) presynaptic 
dopamine levels (Boehme et al., 2015). Dopamine function in the striatum is abnormally elevated in 
both schizophrenia (Abi-Dargham et al., 2000, Breier et al., 1997, Howes et al., 2012, Howes & 
Kapur, 2009, Kumakura et al., 2007, Laruelle et al., 1999, Laruelle et al., 1996, Reith et al., 1994) and 
UHR subjects (Egerton et al., 2013, Howes et al., 2011a, Howes et al., 2011b, Howes et al., 2009b, 
Mizrahi et al., 2014) and the aberrant salience hypothesis proposes that this causes attribution of 
salience to irrelevant stimuli (Heinz & Schlagenhauf, 2010, Winton-Brown et al., 2014). In addition, it 
has been hypothesised that because dopaminergic neurons may show more burst firing in psychosis 
(Goto & Grace, 2005, Winton-Brown et al., 2014) the normal phasic dopaminergic response to 
relevant stimuli may become relatively diminished due to the high level of noise in the system (Heinz, 
2002, Howes et al., 2009a, Kapur, 2003). Psychosis may thus be associated with a reduced attribution 
of salience to relevant stimuli as well as increased attribution of salience to irrelevant stimuli. This is 
consistent with data from recent studies in UHR subjects and in patients with psychosis, which report 
impairments in both forms of salience processing (Pankow et al., 2015, Roiser et al., 2013, Roiser et 
al., 2009).  
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Data from functional neuroimaging studies suggest that UHR subjects and patients with psychosis 
show altered activation in the VS during tasks that engage motivational salience processing. A recent 
meta-analysis suggested that reduced VS responses occur in patients with schizophrenia spectrum 
disorders relative to controls during the processing of contextually relevant information and that left 
VS hypoactivation was more severe in patients with high scores of negative symptoms (Radua et al., 
2015). The relation between VS activation during reward prediction and positive symptoms requires 
further investigation because only six studies were available (de Leeuw et al., 2015, Esslinger et al., 
2012, Nielsen et al., 2012a, Roiser et al., 2013, Simon et al., 2010, Wotruba et al., 2014) and there 
was residual heterogeneity among them (Radua et al., 2015). Interestingly, individual treatment with 
antipsychotics was associated with a normalization of VS activation during reward prediction, and this 
improvement was associated with the improvement of positive symptoms (Nielsen et al., 2012b). With 
respect to contextually irrelevant information, it has been shown that striatal activation during 
incorrect distracter trials was positively correlated with aberrant salience symptoms in schizophrenia 
patients (Ceaser & Barch, 2015). In UHR subjects, the VS response to irrelevant stimulus features was 
found to be associated with the severity of abnormal beliefs (Roiser et al., 2013). However, it is not 
know if altered VS activation during salience processing normalises in UHR individuals whose 
psychotic symptoms have remitted.   
 
The Salience Attribution Test (SAT) is a paradigm that can be used to assess task-relevant and task-
irrelevant motivational salience responses, termed adaptive and aberrant salience, respectively (Roiser 
et al., 2009, Roiser et al., 2010). Our objective was to assess the relationship between changes in 
clinical features in a UHR cohort and longitudinal changes in VS activation elicited during the SAT 
paradigm. Our first hypothesis was that at clinical presentation, UHR subjects would show increased 
aberrant but reduced adaptive salience processing compared to controls, and that these differences 
would be associated with concomitant alterations in VS activation. Our second hypothesis was that 
clinical improvements the UHR subjects subsequent to presentation would be associated with a 
longitudinal normalisation of behavioural and neural responses during salience processing.   
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Methods 
Participants 
Twenty-nine individuals who met the Comprehensive Assessment of At-Risk Mental States 
(CAARMS) (Yung et al., 2005) criteria for the UHR state were recruited from Outreach and Support 
in South London (OASIS (Fusar-Poli et al., 2013b)), a clinical service for people at high-risk for 
psychosis. According to international standard UHR criteria (see (Fusar-Poli et al., 2013a) for a 
comprehensive review), inclusion required the presence of one or more of the following: (i) presence 
of attenuated psychosis symptoms (APS), (ii) genetic risk and deterioration syndrome (GRD), or (iii) 
brief limited and intermittent psychotic symptoms (BLIPS). Twenty-four individuals were included 
based on APS, three based on BLIPS and two based on APS+GRD. Following presentation, all 
subjects were provided with clinical care from OASIS (Fusar-Poli et al., 2013b). Three subjects 
received antipsychotic medication and were thus excluded from the analysis. Twenty-six subjects also 
received cognitive behavioural therapy (CBT), which at the time of writing had been completed in 
nine subjects (twenty-six sessions in average, range 14-65). Seven subjects received low dose 
antidepressants: five citalopram (3 x 20mg, 1x 40 mg, and 1 x unknown dose), one mirtazapine (dose 
unknown) and one sertraline (100 mg). The specific treatments offered by OASIS have been detailed 
elsewhere (Fusar-Poli et al., 2015). All subjects were managed in the community, attending regular 
outpatient appointments.   
Fifteen healthy controls (HCs) from the same geographical area were recruited via local 
advertisements. Absence of psychiatric illness history was confirmed with the Mini International 
Neuropsychiatric Inventory (Sheehan et al., 1998). None of the control subjects had a history of 
neurological illness, DSM-IV drug or alcohol dependence (Association., 2013). All subjects provided 
informed written consent to participate and the study was approved by the local National Health 
Service Research Ethics Committee.   
 
The salience attribution task (SAT) 
The SAT has been previously described in detail elsewhere (Roiser et al., 2009, Roiser et al., 2010). In 
brief, the SAT is a speeded-response game, rewarded with money, which measures responses to cue 
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features, which can be either task-relevant or task-irrelevant. On each trial of the task, participants 
were required to respond to a briefly presented square. Before the square appeared, a cue was shown 
indicating the likelihood of obtaining a reward for the forthcoming response. Participants received a 
monetary reward on 50% of trials, with more money awarded for faster responses. The cues varied in 
two different visual dimensions; colour (red or blue) and shape (animals or household objects). One of 
these cue dimensions was task-relevant and the other task-irrelevant. One task-relevant feature was 
highly associated with receiving a reward, with 87.5% of these trial types rewarded (e.g. blue stimuli). 
The other task-relevant dimension (e.g. red stimuli) was not rewarded on any trials. For the task-
irrelevant dimension, an equal proportion of both features (e.g. animal and household stimuli) were 
rewarded. Participants were not informed about these contingencies, which remained the same over 
the two blocks of 64 trials within a testing session, and instead had to learn them over successive trials 
of the task. To avoid practice effects between baseline and follow-up, four different versions of the 
task were used, counterbalanced across participants, each with a different stimulus feature (blue, red, 
animal or household) rewarded with high probability.   
 
Participants performed the task on two occasions, while being scanned using functional MRI. The 
baseline assessment was performed at the time of clinical presentation. The follow-up assessment was 
carried out approximately 17 months later. On each visit they performed the same version of the task 
twice. The SAT provides behavioural measures of adaptive (relevant) and aberrant (irrelevant) 
motivational salience on the basis of reaction times (RTs: implicit salience) and visual analogue scale 
ratings from 0% to 100% (VAS: explicit salience). Implicit adaptive salience is defined as the 
speeding of responses on high- relative to low-probability reward trials. Explicit adaptive salience is 
defined as the increase in VAS ratings on high- relative to low-probability reward trials. Implicit and 
explicit aberrant salience are defined as the absolute difference in RT and VAS rating, respectively, 
between the two levels of the task-irrelevant stimulus dimension (Roiser et al., 2009).   
 
Behavioural analysis 
Behavioural scores on the SAT were analyzed using a repeated measures analysis of variance 
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(ANOVA) with time as within-subject and group as between-subject factors and years of education as 
a covariate. To test for group differences at baseline and follow-up separately, univariate ANOVA 
with education as covariate was used. Using box-and-whisker plots on each SAT measure for both 
groups separately, two HCs and two UHR subjects were excluded as outliers.   
 
fMRI data acquisition and analysis 
Scanning was performed on a whole-body 3T MRI General Electric (Milwaukee, Wisconsin) system. 
During each of the four scanning runs (two per day), we acquired T2*-weighted echo-planar images 
(EPIs) with the following parameters: 50 axial slices (sequential and top-down acquisition) of 2.4 mm 
thickness, 2.7 mm interslice gap, field of view 240 mm2 and matrix size 64x64. The repetition time 
was 2.5 s and the echo time 25 ms. A total of 237 image volumes were acquired in a single functional 
run.  
EPIs were analyzed using an event-related design with SPM12 (www.fil.ion.ucl.ac.uk/spm). 
Preprocessing was performed for each subject and time point separately. In brief, slice-timing 
correction was first performed on each volume using the middle slice as the reference. The images 
were then realigned to the first image in the series (following removal of dummy scans), spatially 
normalized to the Montreal Neurological Institute (MNI) template and smoothed with a Gaussian 
kernel of 8 mm full half-width maximum (FWHM). All images underwent visual inspection and 
participants with a high number of severely corrupted images and/or gross artefacts were excluded 
(two HCs and one UHRs). Additionally, all images were checked for movement artefacts, and all 
scans with more than 5 mm deviation from the previous scan in any dimension, resulting in corrupted 
volumes, were excluded and replaced with the average of the neighbouring volumes (5.1% in HCs and 
1.5% in UHRs). Subjects with more than 10% corrupted volumes were excluded (two UHRs). In the 
final sample of 23 UHR subjects, 19 subjects were included based on BLIPS, three based on BLIPS 
and one based on APS+GRD.   
Voxel-wise maximum likelihood parameter estimates were calculated during the first level analysis 
using the general linear model. Our design matrix included an autoregressive AR(1) model of serial 
correlations and a high-pass filter with a cutoff of 128 s. The onsets of each event were convolved 
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with the SPM synthetic hemodynamic response function. In this model, we included four ‘cue’ 
regressors, representing the different cue types and an ‘outcome’ regressor representing the time 
points when reward feedback was provided during the task. Cues on which participants failed to 
respond entirely were excluded from the analysis (regressor of no interest) due to the possibility that 
participants were not attending during the trial. Eight contrast images were generated per participant: 
adaptive and aberrant reward prediction at baseline and follow-up separately; average images over 
both visits for adaptive and aberrant reward prediction (to test for main effect of group); and two 
images subtracting the contrast vector of baseline from follow-up (to test for the main effect of time 
and time x group interaction). Adaptive reward prediction contrasts were defined as: high-probability 
reward cue features minus low-probability reward cue features across the task-relevant dimension. 
Aberrant reward prediction contrasts were defined as subjective “high-probability” reward cue 
features minus subjective “low-probability” reward cue features (based on the subject’s VAS ratings 
for that run) across the task-irrelevant dimension (Roiser et al., 2010).   
 
Two-sample tests were conducted at the second level to test for group effects at baseline and follow-
up separately, as well as to test for main effects of group and time and for time x group interactions. 
Significance was assessed at a cluster-level threshold of p<0.05 family-wise error (FWE) corrected 
across the whole brain, using an uncorrected cluster-forming threshold of p<0.001 (Petersson et al., 
1999, Woo et al., 2014) with an extent threshold of 20 voxels. We also focused our analysis on the VS 
as this was part of our primary hypothesis, using a voxel-level approach. The VS region of interest 
was defined using coordinates taken from a previous SAT fMRI study in an independent UHR cohort 
(Roiser et al., 2013): right (x = 12; y = 12; z = –3) and left (x = –12; y = 9; z = –3). Small volume 
correction was applied for this analysis using 15 mm spheres around these coordinates (Roiser et al., 
2013) and a voxel-level threshold of p<0.05 FWE corrected was considered significant. As groups 
differed in years of education, this variable was added as a covariate in the second-level model.   
 
Relationships between brain activation, behaviour and symptoms   
Relationships between neural responses and behavioural and clinical features were identified by 
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including outcome measures from the SAT, CAARMS and Global Assessment of Functioning (GAF) 
as covariates in second level models. The same procedure for correction for multiple comparisons as 
described above was employed. Relationships between behavioural salience responses and 
symptomatology in UHR subjects were tested with Pearson’s correlation coefficients using Statistical 
Package for the Social Sciences (SPSS 16: SPSS Inc., Chicago, IL).   
 
 
 10 
Results 
Demographical and clinical features 
The two groups did not differ in age, gender, handedness, IQ or cigarette, alcohol, cannabis and 
cocaine consumption, but HCs had more years of education (therefore, all group comparisons were co-
varied for years of education). At baseline, UHR subjects had higher scores on CAARMS positive and 
negative symptoms and lower scores on the Global Assessment of Functioning (GAF). Over time, the 
UHR group showed significant improvements in CAARMS positive and negative symptoms, but not 
in GAF scores (Table 1).   
Insert Table 1 about here 
 
Behavioural data 
Aberrant attribution of salience 
Across both visits, UHR subjects showed significantly higher implicit aberrant salience than HCs 
subjects (F(1,34)=6.718, p=0.014), and there was a trend for a group x time interaction 
(F(1,34)=3.225, p=0.081). There was also a trend for a group x time interaction for explicit aberrant 
salience (F(1,34)=3.325, p=0.077). Based on our a priori hypotheses we constructed linear contrasts at 
each time point to test for the predicted group differences in aberrant salience.   
 
At baseline, UHR subjects were more likely than HCs to attribute salience to irrelevant cue features 
(explicit aberrant salience) (F(1,34)=4.732, p=0.037), but did not exhibit greater implicit aberrant 
salience than HCs (F(1,34)=0.964, p=0.333). At follow-up the group difference in explicit aberrant 
salience was no longer significant (F(1,34)=0.061, p=0.806), but HCs had significantly lower implicit 
aberrant scores than the UHR group (F(1,34)=12.296, p=0.001) due to a reduction in this measure over 
time (Figure 1A and B).   
Insert Figure 1 about here 
 
Within the UHR group we detected no significant correlations between aberrant salience responses 
and psychotic symptoms (baseline, follow-up, change over time).  
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Adaptive attribution of salience 
 
Across both visits, the UHR group had lower implicit adaptive salience scores than HCs 
(F(1,34)=11.472, p=0.002), as well as lower explicit adaptive salience scores (F(1,34)=5.493, 
p=0.035). There was also a significant group x time interaction for explicit adaptive salience 
(F(1,34)=4.157, p=0.049).   
 
At baseline, UHR subjects had significantly lower implicit adaptive salience than HCs 
(F(1,34)=13.866, p=0.001) and also exhibited significantly lower explicit adaptive salience 
(F(1,34)=9.043, p=0.005). Both of these group differences were no longer significant at follow-up 
(implicit adaptive salience: F(1,34)=3.733, p=0.062; explicit adaptive salience: F(1,34)=1.360, 
p=0.252), due to improved scores in the UHR group together with relatively stable performance in 
HCs (Figure 2A and B).   
 
Within the UHR group, explicit adaptive salience scores at follow-up were negatively correlated with 
the severity of abnormal beliefs (r=-0.674, p<0.001) (Supplementary Figure 1A) and of positive 
symptoms (r=-0.653, p<0.001) (Supplementary Figure 1B), and positively correlated with the level of 
global functioning (r=0.497, p=0.014) (Supplementary Figure 1C).   
 
Insert Figure 2 about here 
 
All behavioural results remained after excluding the UHR subject with a later transition to psychosis 
(Supplementary information 2A).   
Activation during salience processing 
Aberrant reward prediction 
There were no significant effects of group or time, and no group x time interactions. There were also 
no significant group differences in responses to irrelevant cues at either baseline or follow-up.  
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Adaptive reward prediction 
Across both time points, UHR subjects showed less activation than HCs in the VS, calcarine sulcus 
and midbrain bilaterally and in the left cuneus and middle temporal gyrus (main effect of group: 
Figure 3A, Supplementary Table 1). Across both groups, activation during adaptive reward prediction 
was greater at follow-up than at baseline in the bilateral VS and right thalamus (main effect of time: 
Figure 3B, Supplementary Table 2). No significant group x time interactions were found for adaptive 
reward prediction.   
 
At baseline, the UHR group showed significantly less activation than HCs in the VS bilaterally and the 
left parahippocampal and middle temporal gyrus, and cerebellum during adaptive reward prediction 
(Supplementary Table 3). At follow-up, the UHR group continued to show significantly less activation 
in the VS bilaterally (Supplementary Table 4). All results remained after excluding the UHR subject 
with a later transition to psychosis (Supplementary information 2B).   
 
Insert Figure 3 about here 
 
There were no significant relationships between neural responses from the aberrant and adaptive 
reward prediction contrast and behavioural scores on the SAT (baseline, follow-up, change over time).  
 
Relationship between longitudinal changes in clinical features and brain activation  
Aberrant salience 
There were no significant relationships between changes in clinical features and longitudinal changes 
in brain activation during aberrant reward prediction.   
 
Adaptive salience 
In the UHR group, there was a trend (t22=1.775, p=0.09) for the mean severity of abnormal beliefs to 
improve between presentation and follow-up (Figure 4A). The degree of improvement in abnormal 
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beliefs over time was associated with the longitudinal increase in activation during adaptive reward 
prediction in the right VS and in the supplementary motor cortex bilaterally (Figure 4B and C, 
Supplementary Table 5). This relationship remained after excluding the UHR subject with a later 
transition to psychosis (Supplementary information 2B).   
 
Insert Figure 4 about here 
 
There were no significant correlations between longitudinal changes in negative symptoms and in 
neural responses during motivational salience processing.   
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Discussion 
To our knowledge, this is the first longitudinal investigation of salience processing in subjects with 
psychotic symptoms. We explored the relationship between changes in the clinical features of people 
at UHR for psychosis after they had presented to clinical services and longitudinal changes in their 
behavioural and neural responses during aberrant and adaptive salience processing.   
 
Aberrant salience 
Consistent with the aberrant salience model (Heinz, 2002, Howes & Kapur, 2009, Kapur, 2003), we 
found that UHR subjects were more likely to attribute salience to irrelevant stimuli than HCs at 
clinical presentation. These data are consistent with a previous report of increased explicit aberrant 
salience in an independent UHR sample (Roiser et al., 2013). A study using the SAT in first-episode 
schizophrenia did not find a difference in the patient sample overall, but found that aberrant salience 
was related to the severity of delusions and negative symptoms within the patient group (Roiser et al., 
2009). However, it should be noted that another study found no significant differences between UHR 
subjects, first-episode patients and controls in aberrant salience attribution (Smieskova et al., 2015).   
 
During the 17-month follow-up period, there was a reduction in explicit aberrant salience in UHR 
subjects, such that there was no longer a significant group difference relative to controls. On the basis 
that abnormal salience processing is proposed to underlie the generation of psychotic symptoms 
(Roiser et al., 2013, Roiser et al., 2009), we tested whether longitudinal changes in aberrant salience 
processing were related to changes in clinical features in the UHR subjects during the follow-up 
period. Although UHR subjects showed improvements clinically, there were no significant 
correlations between changes in these variables and longitudinal changes in behavioural measures of 
aberrant salience processing. It has been proposed that the link between aberrant salience and 
symptoms is moderated by cognitive biases (Howes & Murray, 2014), which may account for the lack 
of direct relationship between aberrant salience and symptom change in our data.  
 
Adaptive salience 
 15 
The aberrant salience model proposed that adaptive salience is intact in patients with psychosis, but 
may become impaired as a result of treatment with antipsychotic medication (Heinz, 2002, Kapur, 
2003). The first experimental study of salience processing in first-episode psychosis using the SAT 
found that patients showed impaired adaptive salience, and this was attributed to be an effect of 
antipsychotic treatment (Roiser et al., 2009). However, a subsequent study of largely medication-naïve 
UHR subjects also found a trend for reduced implicit adaptive salience (Roiser et al., 2013). In the 
present study, which involved a larger patient sample, at presentation, UHR subjects showed 
significantly reduced adaptive salience responses. As all of our UHR subjects were naïve to 
antipsychotic medication at this stage, these data not only suggest that adaptive salience is impaired in 
UHR subjects, but that this is not secondary to antipsychotic treatment. Consistent with this 
interpretation, a recent study found that adaptive salience processing was numerically (though not 
significantly) impaired in first-episode psychosis patients, but this impairment was if anything less 
marked in antipsychotic-treated than untreated patients (Smieskova et al., 2015).   
 
Although significant behavioural differences in adaptive salience processing were only present at 
baseline, group differences in activation during adaptive salience processing were seen at both 
presentation and follow-up time-points. At both time points, UHR subjects showed reduced activation 
relative to controls in the VS. This is consistent with a recent meta-analysis demonstrating reduced VS 
activity in response to reward-predicting cues in schizophrenia spectrum disorders (Radua et al., 
2015), and reports of altered VS activation in patients with psychosis during reward prediction error 
tasks (Gradin et al., 2011, Murray et al., 2008). Furthermore, within the UHR group, improvement in 
abnormal beliefs over the follow-up period was correlated with the degree to which VS activation 
increased over time during adaptive reward prediction. This finding is in line with data from 
unmedicated first-episode patients demonstrating a negative correlation between the severity of 
delusional symptoms and reward prediction signals in the VS (Esslinger et al., 2012). Taken with 
longitudinal PET imaging findings that changes in dopamine synthesis capacity in dorsal (associative) 
striatum are associated with change in clinical state (Howes et al., 2011a), our findings suggest that 
alterations in both ventral and dorsal striatum are linked to symptom change. A possible mechanism 
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could be that hyperactive inputs from the hippocampus to the ventral striatum in psychosis may impact 
dopaminergic neurons that project to more dorsal (associative) striatal areas and thereby affect dorsal 
striatum related salience processing (Haber, 2003, Lodge & Grace, 2011, 2012, Modinos et al., 2015).   
The amelioration of abnormal beliefs in UHR subjects was also associated with longitudinal increases 
in activation in the supplementary motor cortex to reward predicting cue features. The latter finding 
was not predicted, as supplementary motor cortex is not specifically implicated in motivational 
salience processing. However, the SAT is a complex task that also involves sustained attention, 
maintaining stimulus information in memory, decision-making and response selection (Roiser et al., 
2013), and the UHR state is associated with a broad range of cognitive impairments (Fusar-Poli et al., 
2012). We therefore speculate that this finding in the supplementary motor cortex may be related to 
alterations in one or more of these processes, possibly secondary to changes in striatal function. 
Furthermore, UHR subjects also showed reduced activation in the calcarine sulcus, cuneus, midbrain 
and middle temporal gyrus across both visits during the attribution of salience to relevant stimuli, as 
well as reduced activation in the parahippocampal gyrus, cerebellum, midbrain, middle temporal 
gyrus, middle and anterior cingulate cortex, inferior frontal gyrus and insula at baseline and/or follow-
up (see supplementary information 1 and 2B for more details). Together with the striatum, integration 
of these regions is important to sustain emotion and cognition, especially during the detection and 
processing of salient information (Menon & Uddin, 2010, Seeley et al., 2007). Dysfunction of this 
network and abnormal network switching when dealing with a relevant task at hand has been proposed 
to underlie the formation of psychotic symptoms (Palaniyappan & Liddle, 2012, Palaniyappan et al., 
2013, Schmidt et al., 2016).   
 
Some limitations of our study merit comment. The sample sizes were modest, largely because 
inclusion required that participants completed multi-modal neuroimaging assessments at both baseline 
and follow-up. The modest group sizes may thus have accounted for the absence of significant group 
differences in activation during aberrant salience processing. A further consideration is that at the time 
of writing, only one UHR subject had developed a psychotic disorder (all results remained after 
excluding this subject, see supplementary information 2A and B for details), precluding any 
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examination of the relationship between abnormal salience processing and the risk of transition to 
psychosis. In this regard, it is possible that the low conversion rate in our UHR sample may explain 
the lack of alterations in brain activation during aberrant salience processing. Future large-scale 
studies with a meaningful ratio between converters and non-converters are required to test if 
functional brain alterations during aberrant reward prediction are evident in UHR subjects who later 
develop psychosis or if the risk of transition to psychosis is more related to impaired activation when 
dealing with a relevant task at hand (i.e. adaptive reward prediction). Furthermore, in accordance with 
aberrant salience model (Kapur, 2003), the SAT has been designed to measure abnormal motivational 
(reward) salience processing in psychosis and its relation to dopamine dysregulation in the VS. 
However, motivation is not the only form of salience (Winton-Brown et al., 2014), and it would be 
important to test ventral and dorsal (associative) striatal activation in psychosis during other forms of 
salience processing that are not measured using speeded response tasks. Finally, subsequent to 
presentation, some of the UHR subjects received CBT or low doses of antidepressants, which may 
have influenced our findings. In this study, the numbers of subjects receiving different forms of 
treatment were too small to allow for meaningful sub-group analyses and this issue would be better 
addressed in longitudinal studies that were explicitly linked to a clinical trial of an intervention that 
might be expected to improve motivational salience processing.   
 
In summary, this study shows that UHR subjects exhibit behavioural deficits in both adaptive and 
aberrant salience processing at clinical presentation, which disappeared along with the remission of 
attenuated psychotic symptoms over the follow-up period. Our results further indicate ventral striatal 
hypoactivation in UHR subjects during adaptive reward prediction at baseline and follow-up and that 
the amelioration of abnormal beliefs over the follow-up period is linked to a longitudinal increase in 
VS activation during adaptive reward prediction.   
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Tables 
Table 1. Demographical and clincal characteristics of the study sample. 
 Healthy controls (n=13) Ultra high-risk subjects (n=23) Group statistics+* 
At Baseline    
Age (years, mean ± SD, [range]) 24.38 ± 5.32 [20-36] 21.57 ± 3.55 [18-29] t34=1.709, p=0.104+ 
Female/male (n) 3/10 11/12 2=2.141, p=0.143+ 
Handedness (R/L) 11/2 22/1 2=1.324, p=0.250+ 
Education (years, mean ± SD ) 14.77 ± 1.64 12.52 ± 2.25 t34=3.436, p=0.002+ 
NART FSIQ (mean ± SD) 111.50 ± 6.10 107.04 ± 9.07 t34=1.578, p=0.124+ 
Cigarettes per day (mean ± SD) 2.69 ± 4.38 5.57 ± 8.13 t34=1.376, p=0.178+ 
Alcohol units per week (mean ± SD) 11 ± 10.52 6.87 ± 9.28 t34=1.179, p=0.251+ 
Cannabis consumption (yes/no) 8/5 14/9 2=0.002, p=0.0968+ 
Cocaine consumption (yes/no) 4/9 8/15 2=0.060, p=0.806+ 
GAF (mean ± SD) 84.15 ± 4.88 59.74 ± 7.61 t34=11.706, p<0.001+ 
CAARMS Positive symptoms (mean ± SD) 0.54 ± 1.20 7.65 ± 3.81 t34=-8.262, p<0.001+ 
CAARMS Negative symptoms (mean ± SD) 0.17 ± 0.58 6.39 ± 3.29 t34=-7.025, p<0.001+ 
    
At Follow-up    
Age (years, mean ± SD, [range]) 25.70 ± 5.33 [21-37] 22.96 ± 3.48 [19-30] t34=1.668, p=0.113+ 
Cigarettes per day (mean ± SD) / 3.13 ± 5.65 t22=1.611, p=0.121* 
Alcohol units per week (mean ± SD) / 7.74 ± 10.82 t22=0.506, p=0.618* 
Cannabis consumption (yes/no) / 14/9 2=0.000, p=1* 
Cocaine consumption (yes/no) / 8/15 2=0.000, p=1* 
GAF (mean ± SD) / 62.39 ± 15.78 t22=0.896, p=0.38* 
CAARMS Positive symptoms (mean ± SD) / 5.22 ± 4.88 t22=2.811, p=0.010* 
CAARMS Negative symptoms (mean ± SD) / 4.22 ± 4.35 t17=2.663, p=0.016* 
 
CAARMS, Comprehensive Assessment of At-Risk Mental States. CAARMS-positive symptoms were the sum of severity scores for unusual thought content 
 24 
(abnormal belief), non-bizarre ideas, perceptual abnormalities and disorganized speed; negative symptoms were the sum of severity scores for alogia, 
avolition/apathy and anhedonia. GAF, Global Assessment of Functioning; NART, National Adult Reading Test Full Scale IQ; SD, standard deviation.   
+ 2-sample t tests and chi-squared tests between groups, respectively. 
* paired tests and chi-squared tests within ultra high-risk subjects between baseline and follow-up assessment.   
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Figure legends 
Figure 1. (A) Implicit (reaction times, msec) and (B) explicit (visual analogue scale) scores for 
aberrant motivational salience processing in healthy controls and subjects at ultra high-risk (UHR) for 
psychosis.   
Figure 2. (A) Implicit (reaction times, msec) and (B) explicit (visual analogue scale) scores for 
adaptive motivational salience processing in healthy controls and subjects at ultra high-risk (UHR) for 
psychosis.   
Figure 3. (A) Greater activation during adaptive reward prediction in healthy controls (HC) compared 
with ultra high-risk (UHR) subjects across both visits. (B) Greater activation at follow-up relative to 
baseline during adaptive reward prediction across both groups. Images are displayed at a cluster-
forming threshold of p<0.001 uncorrected, with an extent threshold of 20 voxels. Colour bars indicate 
t-values.   
Figure 4. (A) Unusual Thought Content (abnormal beliefs) at baseline (mean: 3.04) and follow-up 
(mean: 2.09) in ultra high-risk (UHR) subjects (t22=1.775, p=0.09). (B) Negative correlation between 
changes in brain activation during adaptive reward prediction and changes in abnormal beliefs from 
baseline to follow-up in UHR subjects. The image is displayed at a cluster-forming threshold of 
p<0.001 uncorrected, with an extent threshold of 20 voxels. The colour bar indicates t-values. (C) 
Scatter plot of negative relationship between change in right ventral striatum activation during 
adaptive salience processing (taken from the peak voxel in B) and change in abnormal beliefs 
(CAARMS item unusual thought content) from baseline to follow-up in UHR subjects (r=-0.702).   
 
 
